Physician profile
Eric R Blanson
NPI 1215285135
$44,740.27
in general payments reported to CMS, 2019-2025
32 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,531 · 2020: $63.53 · 2021: $1,571 · 2022: $16K · 2023: $8,013 · 2024: $1,896 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $8,800 · Travel and Lodging: $4,913 · Consulting Fee: $3,750 · Food and Beverage: $3,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $8,800.00 |
| Travel and Lodging | $4,913.23 |
| Consulting Fee | $3,750.00 |
| Food and Beverage | $3,231.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $15,360.00 | 2022 | |
| Convatec INC. | $8,848.48 | 2023-2025 | |
| Dne LLC | $6,226.60 | 2019 | |
| Stryker Corporation | $5,401.01 | 2020-2025 | Prostep, Augment Injectable, Infinity |
| Anika Therapeutics, INC. | $5,030.04 | 2023-2025 | Tactoset, Fna Products, Drawtight |
| Medinc of Texas | $1,255.81 | 2021-2025 | |
| Trimed, INC. | $938.93 | 2025 | |
| Nvision Biomedical Technologies, INC. | $367.28 | 2024 | Trigon |
| Revance Therapeutics, INC. | $274.71 | 2025 | Daxxify |
| Wound Management Technologies, INC | $140.84 | 2019 | |
| Treace Medical Concepts, INC. | $123.13 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $100.91 | 2022 | |
| Biotissue Holdings INC. | $95.11 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $89.35 | 2023-2025 | Nuzyra |
| Medshape, INC. | $50.00 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $42.60 | 2019 | |
| Horizon Therapeutics Plc | $38.62 | 2019-2023 | Krystexxa |
| Mimedx Group, INC. | $34.31 | 2025 | |
| Bioventus LLC | $33.55 | 2019 | |
| Smith+Nephew, INC. | $31.44 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.09 | 2022-2023 | Bryhali, Jublia, Duobrii |
| Imbed Biosciences INC. | $29.50 | 2022 | |
| Amniox Medical, INC. | $25.21 | 2020 | |
| Wright Medical Technology, INC. | $23.49 | 2019 | |
| Melinta Therapeutics, LLC | $21.88 | 2021 | |
| Nevro Corp. | $20.43 | 2024 | Senza |
| Abbott Laboratories | $20.38 | 2023 | Eterna |
| Ermi LLC | $19.08 | 2020 | |
| Biogen, INC. | $18.96 | 2024 | Spinraza |
| Pacira Pharmaceuticals Incorporated | $18.16 | 2024 | Exparel |
| Medtronic, INC. | $16.47 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Blanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.